Functional Dyspepsia Drug Industry Research Report 2023

Functional Dyspepsia Drug Industry Research Report 2023


Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.

Highlights

The global Functional Dyspepsia Drug market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North America is the largest consumer of Functional Dyspepsia Drug in global market, with a consumption market share of 38.71% in 2019. Market is not concentrated.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Functional Dyspepsia Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Functional Dyspepsia Drug.
The Functional Dyspepsia Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Functional Dyspepsia Drug market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Functional Dyspepsia Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Bayer
Sumitomo
Cadila Pharmaceuticals
Teva
Johnson & Johnson
Pfizer
Sanofi
AstraZeneca
Jiangsu Aosaikang Pharma
Eisai
Kyowa Kirin Pharmaceuticals
Hanmi Pharm

Product Type Insights

Global markets are presented by Functional Dyspepsia Drug type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Functional Dyspepsia Drug are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Functional Dyspepsia Drug segment by Type

Prokinetic Drugs
Gastric Antisecretory Drugs
Others

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Functional Dyspepsia Drug market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Functional Dyspepsia Drug market.
Functional Dyspepsia Drug segment by Application

Hospitals
Drugstores

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Functional Dyspepsia Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Functional Dyspepsia Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Functional Dyspepsia Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Functional Dyspepsia Drug industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Functional Dyspepsia Drug.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Functional Dyspepsia Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Functional Dyspepsia Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Functional Dyspepsia Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Frequently Asked Questions

Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Functional Dyspepsia Drug Market Size (2018-2029) & (US$ Million)
2.2.2 Global Functional Dyspepsia Drug Sales (2018-2029)
2.2.3 Global Functional Dyspepsia Drug Market Average Price (2018-2029)
2.3 Functional Dyspepsia Drug by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Prokinetic Drugs
1.2.3 Gastric Antisecretory Drugs
1.2.4 Others
2.4 Functional Dyspepsia Drug by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Hospitals
2.4.3 Drugstores
3 Market Competitive Landscape by Manufacturers
3.1 Global Functional Dyspepsia Drug Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Functional Dyspepsia Drug Sales (M Units) of Manufacturers (2018-2023)
3.3 Global Functional Dyspepsia Drug Revenue of Manufacturers (2018-2023)
3.4 Global Functional Dyspepsia Drug Average Price by Manufacturers (2018-2023)
3.5 Global Functional Dyspepsia Drug Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Functional Dyspepsia Drug, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Functional Dyspepsia Drug, Product Type & Application
3.8 Global Manufacturers of Functional Dyspepsia Drug, Date of Enter into This Industry
3.9 Global Functional Dyspepsia Drug Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Bayer
4.1.1 Bayer Company Information
4.1.2 Bayer Business Overview
4.1.3 Bayer Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Bayer Functional Dyspepsia Drug Product Portfolio
4.1.5 Bayer Recent Developments
4.2 Sumitomo
4.2.1 Sumitomo Company Information
4.2.2 Sumitomo Business Overview
4.2.3 Sumitomo Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Sumitomo Functional Dyspepsia Drug Product Portfolio
4.2.5 Sumitomo Recent Developments
4.3 Cadila Pharmaceuticals
4.3.1 Cadila Pharmaceuticals Company Information
4.3.2 Cadila Pharmaceuticals Business Overview
4.3.3 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Cadila Pharmaceuticals Functional Dyspepsia Drug Product Portfolio
4.3.5 Cadila Pharmaceuticals Recent Developments
4.4 Teva
4.4.1 Teva Company Information
4.4.2 Teva Business Overview
4.4.3 Teva Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Teva Functional Dyspepsia Drug Product Portfolio
4.4.5 Teva Recent Developments
4.5 Johnson & Johnson
4.5.1 Johnson & Johnson Company Information
4.5.2 Johnson & Johnson Business Overview
4.5.3 Johnson & Johnson Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Johnson & Johnson Functional Dyspepsia Drug Product Portfolio
6.5.5 Johnson & Johnson Recent Developments
4.6 Pfizer
4.6.1 Pfizer Company Information
4.6.2 Pfizer Business Overview
4.6.3 Pfizer Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Pfizer Functional Dyspepsia Drug Product Portfolio
4.6.5 Pfizer Recent Developments
4.7 Sanofi
4.7.1 Sanofi Company Information
4.7.2 Sanofi Business Overview
4.7.3 Sanofi Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Sanofi Functional Dyspepsia Drug Product Portfolio
4.7.5 Sanofi Recent Developments
6.8 AstraZeneca
4.8.1 AstraZeneca Company Information
4.8.2 AstraZeneca Business Overview
4.8.3 AstraZeneca Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2018-2023)
4.8.4 AstraZeneca Functional Dyspepsia Drug Product Portfolio
4.8.5 AstraZeneca Recent Developments
4.9 Jiangsu Aosaikang Pharma
4.9.1 Jiangsu Aosaikang Pharma Company Information
4.9.2 Jiangsu Aosaikang Pharma Business Overview
4.9.3 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product Portfolio
4.9.5 Jiangsu Aosaikang Pharma Recent Developments
4.10 Eisai
4.10.1 Eisai Company Information
4.10.2 Eisai Business Overview
4.10.3 Eisai Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Eisai Functional Dyspepsia Drug Product Portfolio
4.10.5 Eisai Recent Developments
6.11 Kyowa Kirin Pharmaceuticals
6.11.1 Kyowa Kirin Pharmaceuticals Company Information
6.11.2 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Business Overview
6.11.3 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product Portfolio
6.11.5 Kyowa Kirin Pharmaceuticals Recent Developments
6.12 Hanmi Pharm
6.12.1 Hanmi Pharm Company Information
6.12.2 Hanmi Pharm Functional Dyspepsia Drug Business Overview
6.12.3 Hanmi Pharm Functional Dyspepsia Drug Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Hanmi Pharm Functional Dyspepsia Drug Product Portfolio
6.12.5 Hanmi Pharm Recent Developments
5 Global Functional Dyspepsia Drug Market Scenario by Region
5.1 Global Functional Dyspepsia Drug Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Functional Dyspepsia Drug Sales by Region: 2018-2029
5.2.1 Global Functional Dyspepsia Drug Sales by Region: 2018-2023
5.2.2 Global Functional Dyspepsia Drug Sales by Region: 2024-2029
5.3 Global Functional Dyspepsia Drug Revenue by Region: 2018-2029
5.3.1 Global Functional Dyspepsia Drug Revenue by Region: 2018-2023
5.3.2 Global Functional Dyspepsia Drug Revenue by Region: 2024-2029
5.4 North America Functional Dyspepsia Drug Market Facts & Figures by Country
5.4.1 North America Functional Dyspepsia Drug Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Functional Dyspepsia Drug Sales by Country (2018-2029)
5.4.3 North America Functional Dyspepsia Drug Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe Functional Dyspepsia Drug Market Facts & Figures by Country
5.5.1 Europe Functional Dyspepsia Drug Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Functional Dyspepsia Drug Sales by Country (2018-2029)
5.5.3 Europe Functional Dyspepsia Drug Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Functional Dyspepsia Drug Market Facts & Figures by Country
5.6.1 Asia Pacific Functional Dyspepsia Drug Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Functional Dyspepsia Drug Sales by Country (2018-2029)
5.6.3 Asia Pacific Functional Dyspepsia Drug Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Functional Dyspepsia Drug Market Facts & Figures by Country
5.7.1 Latin America Functional Dyspepsia Drug Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Functional Dyspepsia Drug Sales by Country (2018-2029)
5.7.3 Latin America Functional Dyspepsia Drug Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Functional Dyspepsia Drug Market Facts & Figures by Country
5.8.1 Middle East and Africa Functional Dyspepsia Drug Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Functional Dyspepsia Drug Sales by Country (2018-2029)
5.8.3 Middle East and Africa Functional Dyspepsia Drug Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Functional Dyspepsia Drug Sales by Type (2018-2029)
6.1.1 Global Functional Dyspepsia Drug Sales by Type (2018-2029) & (M Units)
6.1.2 Global Functional Dyspepsia Drug Sales Market Share by Type (2018-2029)
6.2 Global Functional Dyspepsia Drug Revenue by Type (2018-2029)
6.2.1 Global Functional Dyspepsia Drug Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Functional Dyspepsia Drug Revenue Market Share by Type (2018-2029)
6.3 Global Functional Dyspepsia Drug Price by Type (2018-2029)
7 Segment by Application
7.1 Global Functional Dyspepsia Drug Sales by Application (2018-2029)
7.1.1 Global Functional Dyspepsia Drug Sales by Application (2018-2029) & (M Units)
7.1.2 Global Functional Dyspepsia Drug Sales Market Share by Application (2018-2029)
7.2 Global Functional Dyspepsia Drug Revenue by Application (2018-2029)
6.2.1 Global Functional Dyspepsia Drug Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Functional Dyspepsia Drug Revenue Market Share by Application (2018-2029)
7.3 Global Functional Dyspepsia Drug Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Functional Dyspepsia Drug Value Chain Analysis
8.1.1 Functional Dyspepsia Drug Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Functional Dyspepsia Drug Production Mode & Process
8.2 Functional Dyspepsia Drug Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Functional Dyspepsia Drug Distributors
8.2.3 Functional Dyspepsia Drug Customers
9 Global Functional Dyspepsia Drug Analyzing Market Dynamics
9.1 Functional Dyspepsia Drug Industry Trends
9.2 Functional Dyspepsia Drug Industry Drivers
9.3 Functional Dyspepsia Drug Industry Opportunities and Challenges
9.4 Functional Dyspepsia Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Functional Dyspepsia Drug Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Functional Dyspepsia Drug Sales (M Units) of Manufacturers (2018-2023)
Table 7. Global Functional Dyspepsia Drug Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Functional Dyspepsia Drug Revenue of Manufacturers (2018-2023)
Table 9. Global Functional Dyspepsia Drug Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Functional Dyspepsia Drug Average Price (US$/Unit) of Manufacturers (2018-2023)
Table 11. Global Functional Dyspepsia Drug Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Functional Dyspepsia Drug, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Functional Dyspepsia Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Bayer Company Information
Table 17. Bayer Business Overview
Table 18. Bayer Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 19. Bayer Functional Dyspepsia Drug Product Portfolio
Table 20. Bayer Recent Developments
Table 21. Sumitomo Company Information
Table 22. Sumitomo Business Overview
Table 23. Sumitomo Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 24. Sumitomo Functional Dyspepsia Drug Product Portfolio
Table 25. Sumitomo Recent Developments
Table 26. Cadila Pharmaceuticals Company Information
Table 27. Cadila Pharmaceuticals Business Overview
Table 28. Cadila Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 29. Cadila Pharmaceuticals Functional Dyspepsia Drug Product Portfolio
Table 30. Cadila Pharmaceuticals Recent Developments
Table 31. Teva Company Information
Table 32. Teva Business Overview
Table 33. Teva Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 34. Teva Functional Dyspepsia Drug Product Portfolio
Table 35. Teva Recent Developments
Table 36. Johnson & Johnson Company Information
Table 37. Johnson & Johnson Business Overview
Table 38. Johnson & Johnson Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 39. Johnson & Johnson Functional Dyspepsia Drug Product Portfolio
Table 40. Johnson & Johnson Recent Developments
Table 41. Pfizer Company Information
Table 42. Pfizer Business Overview
Table 43. Pfizer Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 44. Pfizer Functional Dyspepsia Drug Product Portfolio
Table 45. Pfizer Recent Developments
Table 46. Sanofi Company Information
Table 47. Sanofi Business Overview
Table 48. Sanofi Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 49. Sanofi Functional Dyspepsia Drug Product Portfolio
Table 50. Sanofi Recent Developments
Table 51. AstraZeneca Company Information
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 54. AstraZeneca Functional Dyspepsia Drug Product Portfolio
Table 55. AstraZeneca Recent Developments
Table 56. Jiangsu Aosaikang Pharma Company Information
Table 57. Jiangsu Aosaikang Pharma Business Overview
Table 58. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 59. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product Portfolio
Table 60. Jiangsu Aosaikang Pharma Recent Developments
Table 61. Eisai Company Information
Table 62. Eisai Business Overview
Table 63. Eisai Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 64. Eisai Functional Dyspepsia Drug Product Portfolio
Table 65. Eisai Recent Developments
Table 66. Kyowa Kirin Pharmaceuticals Company Information
Table 67. Kyowa Kirin Pharmaceuticals Business Overview
Table 68. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 69. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product Portfolio
Table 70. Kyowa Kirin Pharmaceuticals Recent Developments
Table 71. Hanmi Pharm Company Information
Table 72. Hanmi Pharm Business Overview
Table 73. Hanmi Pharm Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 74. Hanmi Pharm Functional Dyspepsia Drug Product Portfolio
Table 75. Hanmi Pharm Recent Developments
Table 76. Global Functional Dyspepsia Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 77. Global Functional Dyspepsia Drug Sales by Region (2018-2023) & (M Units)
Table 78. Global Functional Dyspepsia Drug Sales Market Share by Region (2018-2023)
Table 79. Global Functional Dyspepsia Drug Sales by Region (2024-2029) & (M Units)
Table 80. Global Functional Dyspepsia Drug Sales Market Share by Region (2024-2029)
Table 81. Global Functional Dyspepsia Drug Revenue by Region (2018-2023) & (US$ Million)
Table 82. Global Functional Dyspepsia Drug Revenue Market Share by Region (2018-2023)
Table 83. Global Functional Dyspepsia Drug Revenue by Region (2024-2029) & (US$ Million)
Table 84. Global Functional Dyspepsia Drug Revenue Market Share by Region (2024-2029)
Table 85. North America Functional Dyspepsia Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. North America Functional Dyspepsia Drug Sales by Country (2018-2023) & (M Units)
Table 87. North America Functional Dyspepsia Drug Sales by Country (2024-2029) & (M Units)
Table 88. North America Functional Dyspepsia Drug Revenue by Country (2018-2023) & (US$ Million)
Table 89. North America Functional Dyspepsia Drug Revenue by Country (2024-2029) & (US$ Million)
Table 90. Europe Functional Dyspepsia Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Europe Functional Dyspepsia Drug Sales by Country (2018-2023) & (M Units)
Table 92. Europe Functional Dyspepsia Drug Sales by Country (2024-2029) & (M Units)
Table 93. Europe Functional Dyspepsia Drug Revenue by Country (2018-2023) & (US$ Million)
Table 94. Europe Functional Dyspepsia Drug Revenue by Country (2024-2029) & (US$ Million)
Table 95. Asia Pacific Functional Dyspepsia Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. Asia Pacific Functional Dyspepsia Drug Sales by Country (2018-2023) & (M Units)
Table 97. Asia Pacific Functional Dyspepsia Drug Sales by Country (2024-2029) & (M Units)
Table 98. Asia Pacific Functional Dyspepsia Drug Revenue by Country (2018-2023) & (US$ Million)
Table 99. Asia Pacific Functional Dyspepsia Drug Revenue by Country (2024-2029) & (US$ Million)
Table 100. Latin America Functional Dyspepsia Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. Latin America Functional Dyspepsia Drug Sales by Country (2018-2023) & (M Units)
Table 102. Latin America Functional Dyspepsia Drug Sales by Country (2024-2029) & (M Units)
Table 103. Latin America Functional Dyspepsia Drug Revenue by Country (2018-2023) & (US$ Million)
Table 104. Latin America Functional Dyspepsia Drug Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East and Africa Functional Dyspepsia Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East and Africa Functional Dyspepsia Drug Sales by Country (2018-2023) & (M Units)
Table 107. Middle East and Africa Functional Dyspepsia Drug Sales by Country (2024-2029) & (M Units)
Table 108. Middle East and Africa Functional Dyspepsia Drug Revenue by Country (2018-2023) & (US$ Million)
Table 109. Middle East and Africa Functional Dyspepsia Drug Revenue by Country (2024-2029) & (US$ Million)
Table 110. Global Functional Dyspepsia Drug Sales by Type (2018-2023) & (M Units)
Table 111. Global Functional Dyspepsia Drug Sales by Type (2024-2029) & (M Units)
Table 112. Global Functional Dyspepsia Drug Sales Market Share by Type (2018-2023)
Table 113. Global Functional Dyspepsia Drug Sales Market Share by Type (2024-2029)
Table 114. Global Functional Dyspepsia Drug Revenue by Type (2018-2023) & (US$ Million)
Table 115. Global Functional Dyspepsia Drug Revenue by Type (2024-2029) & (US$ Million)
Table 116. Global Functional Dyspepsia Drug Revenue Market Share by Type (2018-2023)
Table 117. Global Functional Dyspepsia Drug Revenue Market Share by Type (2024-2029)
Table 118. Global Functional Dyspepsia Drug Price by Type (2018-2023) & (US$/Unit)
Table 119. Global Functional Dyspepsia Drug Price by Type (2024-2029) & (US$/Unit)
Table 120. Global Functional Dyspepsia Drug Sales by Application (2018-2023) & (M Units)
Table 121. Global Functional Dyspepsia Drug Sales by Application (2024-2029) & (M Units)
Table 122. Global Functional Dyspepsia Drug Sales Market Share by Application (2018-2023)
Table 123. Global Functional Dyspepsia Drug Sales Market Share by Application (2024-2029)
Table 124. Global Functional Dyspepsia Drug Revenue by Application (2018-2023) & (US$ Million)
Table 125. Global Functional Dyspepsia Drug Revenue by Application (2024-2029) & (US$ Million)
Table 126. Global Functional Dyspepsia Drug Revenue Market Share by Application (2018-2023)
Table 127. Global Functional Dyspepsia Drug Revenue Market Share by Application (2024-2029)
Table 128. Global Functional Dyspepsia Drug Price by Application (2018-2023) & (US$/Unit)
Table 129. Global Functional Dyspepsia Drug Price by Application (2024-2029) & (US$/Unit)
Table 130. Key Raw Materials
Table 131. Raw Materials Key Suppliers
Table 132. Functional Dyspepsia Drug Distributors List
Table 133. Functional Dyspepsia Drug Customers List
Table 134. Functional Dyspepsia Drug Industry Trends
Table 135. Functional Dyspepsia Drug Industry Drivers
Table 136. Functional Dyspepsia Drug Industry Restraints
Table 137. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Functional Dyspepsia DrugProduct Picture
Figure 5. Global Functional Dyspepsia Drug Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Functional Dyspepsia Drug Market Size (2018-2029) & (US$ Million)
Figure 7. Global Functional Dyspepsia Drug Sales (2018-2029) & (M Units)
Figure 8. Global Functional Dyspepsia Drug Average Price (US$/Unit) & (2018-2029)
Figure 9. Prokinetic Drugs Product Picture
Figure 10. Gastric Antisecretory Drugs Product Picture
Figure 11. Others Product Picture
Figure 12. Hospitals Product Picture
Figure 13. Drugstores Product Picture
Figure 14. Global Functional Dyspepsia Drug Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of Functional Dyspepsia Drug, Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Functional Dyspepsia Drug, Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Functional Dyspepsia Drug Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global Functional Dyspepsia Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global Functional Dyspepsia Drug Sales by Region in 2022
Figure 21. Global Functional Dyspepsia Drug Revenue by Region in 2022
Figure 22. North America Functional Dyspepsia Drug Market Size by Country in 2022
Figure 23. North America Functional Dyspepsia Drug Sales Market Share by Country (2018-2029)
Figure 24. North America Functional Dyspepsia Drug Revenue Market Share by Country (2018-2029)
Figure 25. United States Functional Dyspepsia Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Functional Dyspepsia Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Functional Dyspepsia Drug Market Size by Country in 2022
Figure 28. Europe Functional Dyspepsia Drug Sales Market Share by Country (2018-2029)
Figure 29. Europe Functional Dyspepsia Drug Revenue Market Share by Country (2018-2029)
Figure 30. Germany Functional Dyspepsia Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Functional Dyspepsia Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Functional Dyspepsia Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Functional Dyspepsia Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Functional Dyspepsia Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Functional Dyspepsia Drug Market Size by Country in 2022
Figure 36. Asia Pacific Functional Dyspepsia Drug Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific Functional Dyspepsia Drug Revenue Market Share by Country (2018-2029)
Figure 38. China Functional Dyspepsia Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Functional Dyspepsia Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Functional Dyspepsia Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Functional Dyspepsia Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Functional Dyspepsia Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Functional Dyspepsia Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Functional Dyspepsia Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Functional Dyspepsia Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Functional Dyspepsia Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Functional Dyspepsia Drug Market Size by Country in 2022
Figure 48. Latin America Functional Dyspepsia Drug Sales Market Share by Country (2018-2029)
Figure 49. Latin America Functional Dyspepsia Drug Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Functional Dyspepsia Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Functional Dyspepsia Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Functional Dyspepsia Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East and Africa Functional Dyspepsia Drug Market Size by Country in 2022
Figure 54. Middle East and Africa Functional Dyspepsia Drug Sales Market Share by Country (2018-2029)
Figure 55. Middle East and Africa Functional Dyspepsia Drug Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Functional Dyspepsia Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Functional Dyspepsia Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE Functional Dyspepsia Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Functional Dyspepsia Drug Sales Market Share by Type (2018-2029)
Figure 60. Global Functional Dyspepsia Drug Revenue Market Share by Type (2018-2029)
Figure 61. Global Functional Dyspepsia Drug Price (US$/Unit) by Type (2018-2029)
Figure 62. Global Functional Dyspepsia Drug Sales Market Share by Application (2018-2029)
Figure 63. Global Functional Dyspepsia Drug Revenue Market Share by Application (2018-2029)
Figure 64. Global Functional Dyspepsia Drug Price (US$/Unit) by Application (2018-2029)
Figure 65. Functional Dyspepsia Drug Value Chain
Figure 66. Functional Dyspepsia Drug Production Mode & Process
Figure 67. Direct Comparison with Distribution Share
Figure 68. Distributors Profiles
Figure 69. Functional Dyspepsia Drug Industry Opportunities and Challenges

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings